Literature DB >> 12795803

What should be the cut-off level of serum CA125 to evaluate the disease status before second-look laparotomy in epithelial ovarian carcinoma?

T Beşe1, F Demirkiran, M Arvas, A U Oz, D Kösebay, E Erkün.   

Abstract

To assess the predictive value of serum CA125 level prior to second-look laparotomy in epithelial ovarian carcinoma, 45 patients who were clinically or radiologically tumor-free prior to a second-look laparotomy were studied. Serum CA125 levels were measured 10 days prior to the operation, and were compared with the surgico-pathological results. Twenty-eight (62%) patients were found to have tumor at surgery. The serum CA125 levels were > or = 35 U ml-1 (42%) patients. Tumors were found in 14 (74%) of these 19 patients. Although a serum CA125 level > or = 35 U ml-1 was a strong predictor of the presence of an intraperitoneal tumor, a level <35 U ml-1 was not predictive of a tumor-free state. When the cut-off level was accepted as 20 U ml-1, 28 patients (62%) were found to have elevated CA125 level. The sensitivity, the specificity, the positive and negative predictive value and the false negative ratio were calculated as 79%, 65%, 79%, 65% and 21% respectively. The threshold value for a raised CA125 level was considered and a lower level of 20 U ml-1 was suggested as a cut-off level prior to second-look laparotomy in evaluating patients with known epithelial ovarian cancer.

Entities:  

Year:  1997        PMID: 12795803     DOI: 10.1046/j.1525-1438.1997.00422.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  3 in total

1.  Lights and shadows of the tumoral marker CA-125 in ovarian cancer.

Authors:  A Sánchez Muñoz; A González Martín; C Mendiola Fernández
Journal:  Clin Transl Oncol       Date:  2008-08       Impact factor: 3.405

2.  Does serum CA125 have clinical value for follow-up monitoring of postoperative patients with epithelial ovarian cancer? Results of a 12-year study.

Authors:  Na Guo; Zhilan Peng
Journal:  J Ovarian Res       Date:  2017-03-11       Impact factor: 4.234

3.  Nadir CA-125 has prognostic value for recurrence, but not for survival in patients with ovarian cancer.

Authors:  Szymon Piatek; Grzegorz Panek; Zbigniew Lewandowski; Dominika Piatek; Przemyslaw Kosinski; Mariusz Bidzinski
Journal:  Sci Rep       Date:  2021-09-14       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.